Erratum: Evidence of a stabilizing mutation of β-catenin encoded by CTNNB1 exon 3 in a large series of sporadic parathyroid adenomas (Endocrine, (2012) 42, 3 (612-615), 10.1007/s12020-012-9690-3);Evidence of a stabilizing mutation of β-catenin encoded by CTNNB1 exon 3 in a large series of sporadic parathyroid adenomas

Endocrine

Volumn 42, Issue 3, 2012, Pages 612-615

  Starker, Lee F ^a,b   Fonseca, Annabelle L ^a   Åkerström, Göran ^b   Björklund, Peyman ^b   Westin, Gunnar ^b   Carling, Tobias ^a,c  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UPPSALA UNIVERSITY   (Sweden)

^c YALE CANCER CENTER   (United States)

Author keywords

Beta catenin; Parathyroid; Primary hyperparathyroidism

Indexed keywords

BETA CATENIN; GLYCOGEN SYNTHASE KINASE 3BETA; SERINE; CTNNB1 PROTEIN, HUMAN; DNA; GLYCOGEN SYNTHASE KINASE 3; GLYCOGEN SYNTHASE KINASE 3 BETA;

ADULT; ARTICLE; CONTROLLED STUDY; CTNNB1 GENE; DNA SEQUENCE; ENZYME PHOSPHORYLATION; EXON; FEMALE; GENE MUTATION; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MALE; PARATHYROID ADENOMA; POLYMERASE CHAIN REACTION; PRIMARY HYPERPARATHYROIDISM; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN STABILITY; ADENOMA; GENETICS; MIDDLE AGED; MUTATION; PARATHYROID TUMOR; PHYSIOLOGY;

ADENOMA; BETA CATENIN; DNA; EXONS; FEMALE; GLYCOGEN SYNTHASE KINASE 3; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MIDDLE AGED; MUTATION; PARATHYROID NEOPLASMS; POLYMERASE CHAIN REACTION;

EID: 84878263379     PISSN: 1355008X     EISSN: 15590100     Source Type: Journal    
DOI: 10.1007/s12020-012-9763-3     Document Type: Erratum

References (21)

1. H. Heath 3rd, S.F. Hodgson, M.A. Kennedy, Primary hyperparathyroidism. Incidence, morbidity, and potential economic impact in a community. N. Engl. J. Med. 302, 189-193 (1980)
2. E. Lundgren, E. Szabo, S. Ljunghall, R. Bergstrom, L. Holmberg, J. Rastad, Population based case-control study of sick leave in postmenopausal women before diagnosis of hyperparathyroidism. BMJ 317, 848-851 (1998)
3. S.J. Silverberg, E.M. Lewiecki, L. Mosekilde, M. Peacock, M.R. Rubin, Presentation of asymptomatic primary hyperparathyroidism: proceedings of the third international workshop. J. Clin. Endocrinol. Metab. 94, 351-365 (2009)
4. C.A. Verdonk, A.J. Edis, Parathyroid "double adenomas": fact of fiction? Surgery 90, 523-526 (1981)
5. P.K. Lee, S.L. Jarosek, B.A. Virnig, M. Evasovich, T.M. Tuttle, Trends in the incidence and treatment of parathyroid cancer in the United States. Cancer 109, 1736-1741 (2007)
6. L.E. Tisell, S. Carlsson, M. Fjalling, G. Hansson, S. Lindberg, L.M. Lundberg, A. Oden, Hyperparathyroidism subsequent to neck irradiation risk factors. Cancer 56, 1529-1533 (1985)
7. G. Westin, P. Bjorklund, G. Akerstrom, Molecular genetics of parathyroid disease. World J. Surg. 33, 2224-2233 (2009)
8. T. Carling, P. Correa, O. Hessman, J. Hedberg, B. Skogseid, D. Lindberg, J. Rastad, G. Westin, G. Akerstrom, Parathyroid MEN1 gene mutations in relation to clinical characteristics of nonfamilial primary hyperparathyroidism. J. Clin. Endocrinol. Metab. 83, 2960-2963 (1998)
9. F. Farnebo, B.-T. Teh, S. Kytölä, A. Svensson, C. Phelan, K. Sandelin, N.W. Thompson, A. Höög, G. Weber, L.-O. Farnebo, C. Larsson, Alterations of the MEN1 gene in sporadic parathyroid tumors. J. Clin. Endocrinol. Metab. 83, 2627-2630 (1998)
10. A. Arnold, H.G. Kim, Clonal loss of one chromosome 11 in a parathyroid adenoma. J. Clin. Endocrinol. Metab. 69, 496-499 (1989)
11. M. Shtutman, J. Zhurinsky, I. Simcha, C. Albanese, M. D'Amico, R. Pestell, A. Ben-Ze'ev, The cyclin D1 gene is a target of the beta-catenin/LEF-1 pathway. Proc Natl Acad Sci USA 96, 5522-5527 (1999)
12. P. Bjorklund, D. Lindberg, G. Akerstrom, G. Westin, Stabilizing mutation of CTNNB1/beta-catenin and protein accumulation analyzed in a large series of parathyroid tumors of Swedish patients. Mol. Cancer 7, 53 (2008)
13. P. Bjorklund, G. Akerstrom, G. Westin, Accumulation of nonphosphorylated beta-catenin and c-myc in primary and uremic secondary hyperparathyroid tumors. J. Clin. Endocrinol. Metab. 92, 338-344 (2007)
14. P. Bjorklund, G. Akerstrom, G. Westin, Activated beta-catenin in the novel human parathyroid tumor cell line sHPT-1. Biochem. Biophys. Res. Commun. 352, 532-536 (2007)
15. J. Costa-Guda, A. Arnold, Absence of stabilizing mutations of beta-catenin encoded by CTNNB1 exon 3 in a large series of sporadic parathyroid adenomas. J. Clin. Endocrinol. Metab. 92, 1564-1566 (2007)
16. S. Ikeda, Y. Ishizaki, Y. Shimizu, M. Fujimori, Y. Ojima, M. Okajima, K. Sugino, T. Asahara, Immunohistochemistry of cyclin D1 and beta-catenin, and mutational analysis of exon 3 of beta-catenin gene in parathyroid adenomas. Int. J. Oncol. 20, 463-466 (2002)
17. S. Semba, R. Kusumi, T. Moriya, H. Sasano, Nuclear accumulation of B-catenin in human endocrine tumors: association with Ki-67 (MIB-1) proliferative activity. Endocr. Pathol. 11, 243-250 (2000)
18. P. Bjorklund, G. Akerstrom, G. Westin, An LRP5 receptor with internal deletion in hyperparathyroid tumors with implications for deregulated WNT/beta-catenin signaling. PLoS Med 4, e328 (2007)
19. F. Haglund, A. Andreasson, I.L. Nilsson, A. Hoog, C. Larsson, C.C. Juhlin, Lack of S37A CTNNB1/beta-catenin mutations in a Swedish cohort of 98 parathyroid adenomas. Clin. Endocrinol. (Oxf) 73, 552-553 (2010)
20. P. Polakis, The oncogenic activation of beta-catenin. Curr. Opin. Genet. Dev. 9, 15-21 (1999)
21. V. Guarnieri, F. Baorda, C. Battista, M. Bisceglia, T. Balsamo, E. Gruppioni, M. Fiorentino, L.A. Muscarella, M. Coco, R. Barbano, S. Corbetta, A. Spada, D.E. Cole, L. Canaff, G.N. Hendy, M. Carella, A. Scillitani. A rare S33C mutation of CTNNB1 encoding β-catenin in a parathyroid adenoma found in an Italian primary hyperparathyroid cohort. Endocrine (2011) doi: 10.1007/s12020-011-9558-y